Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 175 of 2051 entries
View as:

Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)

Phase: N/A Priority: Normal
NCT ID: NCT00871871 Org: User:
Start: 03/31/09 End: 03/31/10 Due: 03/31/11

A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)

Phase: N/A Priority: Normal
NCT ID: NCT01385566 Org: User:
Start: 09/30/11 End: 05/31/13 Due: 05/31/14

MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)

Phase: N/A Priority: Normal
NCT ID: NCT00543010 Org: User:
Start: 11/30/02 End: 11/30/03 Due: 11/30/04

Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)

Phase: N/A Priority: Normal
NCT ID: NCT00875056 Org: User:
Start: 04/15/09 End: 02/08/19 Due: 02/08/20

A Study in Adult and Pediatric Patients With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00034515 Org: User:
Start: 06/30/01 End: 08/31/02 Due: 08/31/03

Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)

Phase: N/A Priority: Normal
NCT ID: NCT00844805 Org: User:
Start: 09/30/09 End: 09/30/11 Due: 09/30/12

Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)

Phase: N/A Priority: Normal
NCT ID: NCT00693472 Org: User:
Start: 08/15/07 End: 01/09/09 Due: 01/09/10

Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)

Phase: N/A Priority: Normal
NCT ID: NCT01075984 Org: User:
Start: 02/23/10 End: 11/20/12 Due: 11/20/13

The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

Phase: N/A Priority: Normal
NCT ID: NCT00990808 Org: User:
Start: 11/30/09 End: 07/31/11 Due: 07/31/12

Effects of Insomnia on Simulated Driving (MK-0000-183-00)

Phase: N/A Priority: Normal
NCT ID: NCT01209728 Org: User:
Start: 10/01/10 End: 09/01/11 Due: 09/01/12

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

Phase: N/A Priority: Normal
NCT ID: NCT06979596 Org: User:
Start: 07/17/25 End: 07/17/30 Due: 07/17/31

Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT00625612 Org: User:
Start: 02/29/08 End: 10/31/10 Due: 10/31/11

An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00131430 Org: User:
Start: 08/31/05 End: 05/31/07 Due: 05/31/08

A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00736333 Org: User:
Start: 11/30/06 End: 06/30/10 Due: 06/30/11

Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)

Phase: N/A Priority: Normal
NCT ID: NCT01813513 Org: User:
Start: 01/31/13 End: 07/31/13 Due: 07/31/14

MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)

Phase: N/A Priority: Normal
NCT ID: NCT01299376 Org: User:
Start: 01/24/11 End: 09/20/12 Due: 09/20/13

A Study of Single Doses of Frespaciguat (MK-5475) on Pulmonary Vascular Resistance (MK-5475-002)

Phase: N/A Priority: Normal
NCT ID: NCT03744637 Org: User:
Start: 01/18/19 End: 12/11/20 Due: 12/11/21

A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144)

Phase: N/A Priority: Normal
NCT ID: NCT00945750 Org: User:
Start: 08/31/06 End: 09/30/06 Due: 09/30/07

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00126451 Org: User:
Start: 12/01/04 End: 10/11/05 Due: 10/11/06

Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560)

Phase: N/A Priority: Normal
NCT ID: NCT00723840 Org: User:
Start: 09/30/06 End: 12/31/09 Due: 12/31/10

Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)

Phase: N/A Priority: Normal
NCT ID: NCT02853331 Org: User:
Start: 09/16/16 End: 12/31/25 Due: 12/31/26

A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)

Phase: N/A Priority: Normal
NCT ID: NCT00631488 Org: User:
Start: 02/29/08 End: 01/31/09 Due: 01/31/10

KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B)

Phase: N/A Priority: Normal
NCT ID: NCT04165083 Org: User:
Start: 12/22/20 End: 09/17/25 Due: 09/17/26

Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)

Phase: N/A Priority: Normal
NCT ID: NCT01422304 Org: User:
Start: 10/12/11 End: 09/26/12 Due: 09/26/13

A Radiolabeled Mass Balance Study of [14C]-Ertugliflozin (PF04971729, MK-8835) In Healthy Male Participants (MK-8835-038)

Phase: N/A Priority: Normal
NCT ID: NCT01127308 Org: User:
Start: 06/30/10 End: 07/31/10 Due: 07/31/11